Insight Molecular Diagnostics Inc. (LON:0KCC)
5.57
-0.15 (-2.58%)
Feb 12, 2026, 3:42 PM GMT
Insight Molecular Diagnostics Employees
As of December 31, 2024, Insight Molecular Diagnostics had 49 total employees, including 46 full-time and 3 part-time employees. The number of employees increased by 3 or 6.52% compared to the previous year.
Employees
49
Change (1Y)
3
Growth (1Y)
6.52%
Revenue / Employee
68.23K GBP
Profits / Employee
-941.98K GBP
Market Cap
135.01M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 49 | 3 | 6.52% | 46 | 3 |
| Dec 31, 2023 | 46 | -30 | -39.47% | 43 | 3 |
| Dec 31, 2022 | 76 | -39 | -33.91% | 75 | 1 |
| Dec 31, 2021 | 115 | 64 | 125.49% | 110 | 5 |
| Dec 31, 2020 | 51 | 18 | 54.55% | 51 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| EKF Diagnostics Holdings | 297 |
| Tristel | 267 |
| Diaceutics | 213 |
| Animalcare Group | 201 |
Insight Molecular Diagnostics News
- 6 months ago - OncoCyte Q2 2025 Earnings Preview - Seeking Alpha
- 8 months ago - Oncocyte changes name to Insight Molecular Diagnostics and moves headquarters to Nashville - Seeking Alpha
- 8 months ago - Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville - GlobeNewsWire
- 9 months ago - Medicare Boosts Reimbursement for Oncocyte's Flagship Technology - GlobeNewsWire
- 9 months ago - OncoCyte targets 20 transplant center milestone and upcoming FDA submission while advancing rebranding initiative - Seeking Alpha
- 9 months ago - OncoCyte Corporation (OCX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 9 months ago - OncoCyte GAAP EPS of -$0.26 misses by $0.02, revenue of $2.13M beats by $2M - Seeking Alpha
- 9 months ago - Oncocyte Reports Q1 2025 Results and Business Progress - GlobeNewsWire